Frequent ventricular extrasystoles: significance,

prognosis and treatment

An article from the E-Journal of the ESC Council for Cardiology Practice
Vol.9,N°17 - 28 Jan 2011

Frequent and apparently idiopathic premature ventricular contractions (PVCs) are usually considered a benign
condition that can be managed with conservative measures. B-blockers are usually very effective.
Radiofrequency catheter ablation therapy has generally been reserved for patients with frequent PVCs whose
quality of life is disturbed by bothersome symptoms or patients with sustained ventricular tachycardia.
Topic(s):
Arrhythmias

It is a relatively common occurrence for cardiovascular clinicians to see patients with frequent premature
ventricular contractions. They may appear in patients without any overt cardiovascular disease, in which case
pathogenesis can be considered idiopathic. However, although largely asymptomatic, patients with PVCs
can experience upsetting symptoms and there are occasions when the presence of PVCs signifies susceptibility
towards more sinister arrhythmias, especially when heart disease is present. Premature ventricular contraction in
certain patients are triggered by the same mechanisms that give rise to ventricular tachycardia, which may be
cured with catheter ablation. Appropriate clinical evaluation and investigations are important in assessing
patients so that effective treatment can be targeted.

I - Prevalence and Prognosis

Premature ventricular contractions have been described in 1% of clinically normal people as detected by a
standard ECG and 40–75% of apparently healthy persons as detected by 24–48 hour ambulatory (Holter) ECG
recordings. Kennedy et al demonstrated that frequent (>60/h or 1/min) and complex PVCs could occur in
apparently healthy subjects, with an estimated prevalence of 1–4% of the general population.(1) Further to
demonstrationg that frequent and complex ventricular ectopy could occur in healthy subjects, they also showed
it could be associated with a benign prognosis.
Additionaly, both the incidence and complexity of PVCs is increased in almost all heart disease, and could be
90% in coronary artery disease and dilated cardiomyopathy. (2,3)Other studies such as MRFIT (4) and data
from the Framingham Heart Study (5), have linked the frequent occurrence of PVCs with an increased risk of
sudden cardiac death and death from any cause. However, these studies have been criticised for the lack of
rigorous measures to exclude underlying heart disease confounded, which can halve the outcome regarding
death.
These irregularities did not interfere with normal lifespan when they were occasional but an ominous prognosis
was implied if they were frequent. This was shown to be so in more recent times where patients who have had a
myocardial infarction were more prone to sudden death if they had frequent PVCs (5).
Nevertheless, recent studies have documented that the LV dysfunction in patients with frequent PVCs could
recover after elimination of the PVCs by medical treatment or catheter ablation therapy in certain cases. (6-10)

II - Clinical Features

The length and morphology of PVCs are highly variable and depend on the place of origin, the presence of
structural heart disease and treatment with antiarrhythmic drugs. In general, QRS duration is mostly longer than
120 ms, because the activation spread occurs from a ventricle to the contralateral one through non-specialised
myocardium (figure 1). However, when activation comes from one of the fascicle through a specific conduction
system, both ventricles could be activated "synchronously", which may result in a QRS complex of less than
120 ms. (11)
Premature ventricular contractions can be classified in various ways, depending on 1) coupling interval (early
and delayed), 2) QRS duration (wide and narrow), 3) morphology and 4) complexity. The morphology of PVCs
is of great importance in patients susceptible to be treated by catheter ablation, because the 12-lead EKG can
identify the origin of PVCs with a certain degree of precision. As a general rule, PVCs originating in the left
ventricle have right bundle branch block morphology, and PVCs originating in the right ventricle, have a left
bundle branch block pattern.
Frequent PVCs can also be observed in patients with hypertension. (12) In the MRFIT Population cohort of
over 10 000 men aged 35-57 years, the level of systolic blood pressure was linked with the prevalence of PVCs.
More recent data in the Atherosclerosis Risk in Communities (ARIC) study (13) of more than 15 000 white and
African American men and women presented extended findings that showed frequent or complex PVCs that are
also associated with hypertension. The Framingham study has indicated that patients with left ventricular
hypertrophy by electrocardiographic criteria are at greater risk of sudden death and acute myocardial infarction
than subjects with a normal heart. The ARIC study also demonstrated that the prevalence of PVCs Increases
with the electrocardiographic Increases of left ventricular mass.
In some cases, PVCs may be the first manifestation of underlying structural heart disease. For this reason, in all
patients with PVCs, the clinician must perform a detailed clinical history of 12-lead EKG and chest X-ray.
Although the relationship between frequent PVCs originating from the ventricular outflow tract and
arrhythmogenic right ventricular cardiomyopathy was once suggested. (14) The indication of a record EKG-
Holter, a stress test or echocardiogram, depends on whether PVCs persist after the initial evaluation of
suspected structural heart disease or the development of complex forms of ventricular arrhythmias.
For more than 20 years now, it has been accepted that the presence of PVCs in the absence of structural heart
disease entails a favorable benign prognosis, even when they arise frequently. For this reason and because of the
proarrhythmic potential of antiarrhythmic drugs (see later), the physician does not need to treat PVCs in this
clinical setting, except when the PVCs are responsible for many symptoms. Nevertheless, in some cases very
frequent PVCs can produce ventricular dilation and dysfunction (tachycardiomyopathy), the latter being an
indication for treatment (ablation or antiarrhythmic drugs), even in the absence of symptoms. However, the
clinical importance of frequent PVCs in patients without any LV dysfunction is still unclear.
The prognostic significance of PVCs in ischemic heart disease is less benign. Indeed, in patients who have
suffered a myocardial infarction, the presence of PVCs has been associated with an increase of up to 3 times the
risk of sudden death. (2,3,15)

There are conflicting results as to the meaning of PVCs in stress testing. Frolkis et al, demonstrated that the
presence of frequent PVCs during recovery from exercise testing is a better predictor of the risk of sudden death
than the isolated presence of PVCs reached during the effort. (16)
Caffeine is a central stimulant which can increase sympathetic activity. Clinical impression and anecdotes often
associate arrhythmias with consumption of caffeine, alcohol and tobacco has been widely practiced in managing
patients with palpitation despite the relative lack of direct evidence. Animal studies have shown that caffeine
administration at high doses could induce and increase the frequency of PVCs. Some epidemiological data exist
with an association between PVCs activity with caffeine intake, but experimental human studies have not
produced consistent results to establish this link.

III - Management

The thinking behind the necessity to suppress PVCs was studied in the Cardiac Arrhythmia Suppression Trial
(CAST).(17) This study hypothesis that the suppression of asymptomatic PVCs or minimally symptomatic after
myocardial infarction, would reduce arrhythmic death. The authors concluded that treatment with Flecainide
and Encainide was an independent risk factor for arrhythmic cause death, cardiac death and non-arrhythmic
mortality. This excess mortality was independent of time post-AMI. This Further study highlights the
proarrhythmic effect of these drugs in patients with heart disease and disputes the notion of using drugs simply
for the sake of suppressing PVCs.
PVCs originating from the RVOT have been associated with malignant ventricular arrhythmias. The ability of
frequent PVCs originating from a focal source in triggering idiopathic ventricular fibrillation (VF) in seemingly
normal hearts was first reported by Haissaguerre et al. (18) The PVCs were mapped to sites at the RVOT and
also along the distal Purkinje system in both left and right ventricles. Catheter ablation was shown to be
effective in acutely eliminating VEBs and reducing the incidence of further VF recurrence. Similar triggers
have been shown in ablation. selected patients with long QT and Brugada syndromes with report of successful
elimination of PVCs with catheter Further studies in large numbers of patients with longer follow up are
required to assess the full prognostic benefit of this approach. Progressive PVCs are induced with exercise or
stress which can cause syncope or sudden death with polymorphic VT or VF. Treatment is usually with b
blockers and ICD implantation.

Summary of the treatment of patients with Premature Ventricular

Contractions (PVCs) (19)

1. Ventricular ectopic beats (PVCs) are frequently seen in daily clinical practice and are usually benign.
2. Presence of heart disease should be sought and, if absent, indicates good prognosis in patients with PVCs.
3. There is no clear evidence that caffeine restriction is effective in reducing PVCs frequency, but patients with
excessive caffeine intake should be cautioned and appropriately advised if symptomatic with PVCs.
4. Unifocal PVCs arising from the right ventricular outflow tract are common and may increase with exercise
and cause non-sustained or sustained ventricular tachycardia. Catheter ablation is effective and safe treatment for
these patients.
5. B-blockers may be used for symptom control in patients where PVCs arise from multiple sites. It should also
be considered in patients with impaired ventricular systolic function and/or heart failure.
6. Risk of sudden cardiac death from malignant ventricular arrhythmia should be considered in patients with
heart disease who have frequent PVCs. Implantable cardioverter- defibrillator may be indicated if risk stratification
criteria are met.
7. PVCs have also been shown to trigger malignant ventricular arrhythmias in certain patients with idiopathic
ventricular fibrillation and other syndromes. Catheter ablation may be considered in some patients as adjunctive
treatment.

Figure 1 : 55 years-old patient with frequent and asymptomatic premature ventricular contractions.

Conclusion:
It is a relatively common occurrence for cardiovascular clinicians to see patients with frequent premature
ventricular contractions. Frequent and apparently idiopathic PVCs are usually considered a benign condition
that can be managed with conservative measures. B-blockers are usually very effective. Radiofrequency
catheter ablation has generally been reserved for patients with frequent PVCs whose quality of life is disturbed
by bothersome symptoms or patients with sustained VT. Most of the remaining patients exhibit no severe
clinical symptoms, and so the condition of those patients with frequent PVCs without any overt symptoms, is
believed to be relatively benign.

References

1. Kennedy HL, Whitlock JA, Sprague MK, et al. Long-term follow-up of asymptomatic healthy subjects with
frequent and complex ventricular ectopy. N Engl J Med 1985;312:193–7.
2. Bigger J, Dresdale R, Heissenbuttel R, et al. Ventricular arrhythmias in isquemic heart disease: mechanism,
prevalence, significance and management. Prog Cardiovascular Dis 1977;19:255-300.
3. Moss A, Davis H, Camilla J, et al. Ventricular ectopic beat and their relation to sudden and non sudden
cardiac death after myocardial infarction. Circulation 1979;60:998-1003.
4. Abdalla IS, Prineas RJ, Neaton JD, et al. Relation between ventricular premature complexes and sudden
cardiac death in apparently healthy men. Am J Cardiol 1987;60:1036–42.
5. Bikkina M, Larson MG, Levy D. Prognostic implications of asymptomatic ventricular arrhythmias: the
Framingham Heart Study. Ann Intern Med1992;117:990–6.
6. Zalzstein E, Wagshal A, Zucker N, et al. Ablation therapy of tachycardia-related cardiomyopathy. Isr Med
Assoc J 2003;5:64–5.
7. Redfearn DP, Hill JD, Keal R, et al. Left ventricular dysfunction resulting from frequent unifocal ventricular
ectopics with resolution following radiofrequency ablation. Europace 2003;5:247–50.
8. Takemoto M, Yoshimura H, Ohba Y, et al. Radiofrequency catheter ablation of premature ventricular
complexes from right ventricular outflow tract improves left ventricular dilation and clinical status in patients
without structural heart disease. J Am Coll Cardiol 2005;45:1259–65.
9. Bogun F, Crawford T, Reich S, et al. Radiofrequency ablation of frequent, idiopathic premature ventricular
complexes: Comparison with a control group without intervention. Heart Rhythm 2007;4:863–7.
10. Sekiguchi Y, Aonuma K, Yamauchi Y, et al. Chronic hemodynamic effects alter radiofrequency catheter
ablation of frequent monomorphic ventricular premature beats. J Cardiovasc Electrophysiol 2005;16:1057–63.
11. Elizari M. Arritmias cardíacas. En: Bertolasi C Ed. Cardiología 2000. Buenos Aires: Editorial
Panamericana, 2001;3051-12.
12. Simpson RJ Jr, Cascio WE, Schreiner PJ, et al. Prevalence of premature ventricular contractions in a
population of African American and white men and women: the Atherosclerosis Risk in Communities (ARIC)
study. Am Heart J 2002;143:535–40.
13. Almendral J, Villacastin JP, Arenal A, et al. Evidence favoring the hypothesis that ventricular arrhythmias
have prognostic significance in left ventricular hypertrophy secondary to systemic hypertension. Am J Cardiol
1995;76:60D–3D.
14. O’Donnell D, Cox D, Bourke J, et al. Clinical and electrophysiological differences between patients with
arrhythmogenic right ventricular dysplasia and right ventricular outflow tract tachycardia. Eur Heart J
2003;24:801–10.
15. Coronary Drugs Project Research Group: Prognostic importance of premature beats following myocardial
infarction: experience in the Coronary Drugs Project. JAMA 1973:224:1116-24.
16. Frolkis J, Pothier C, Blackstone E, et al. Frequent ventricular ectopy after exercise as a predictor of death. N
Engl J med 2003;348:781-90.
17. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide
and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl
J Med 1989;321:406–12.
18. Haissaguerre M, Shah DC, Jais P, et al. Role of Purkinje conducting system in triggering of idiopathic
ventricular fibrillation. Lancet 2002;359:677–8
19. G André Ng. Treating patients with ventricular ectopic beats. Heart 2006;92:1707–12.
VolumeNumber:
Vol9 N°17
The content of this article reflects the personal opinion of the author/s and is not necessarily the official position of
the European Society of Cardiology.

Our mission: To reduce the burden of cardiovascula